Sree Rayalaseema Hi-Strength Hypo Limited reported a net profit of ₹9269.56 lakh for the financial year ended March 31, 2026, compared to ₹9267.52 lakh in the previous year. For the quarter ended March 31, 2026, the net profit stood at ₹2057.20 lakh, down from ₹2271.02 lakh in the corresponding quarter of the previous year. The Board of Directors recommended a final dividend of ₹3 per equity share, subject to shareholder approval at the ensuing Annual General Meeting.

The total income from operations for the quarter rose to ₹18105.43 lakh from ₹17581.13 lakh in Q4FY25. On an annual basis, the total income reached ₹72181.59 lakh for the year ended March 31, 2026. The financial results were reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on May 30, 2026.

The company reported a total comprehensive income of (₹3,777.09) lakh for the quarter, compared to ₹720.33 lakh in the prior year period. For the year ended March 31, 2026, the total comprehensive income was ₹5923.23 lakh. The paid-up equity share capital remained constant at ₹1716.48 lakh with a face value of ₹10 each.

Earnings per share (EPS) for the quarter ended March 31, 2026, stood at ₹11.98 on a basic basis, down from ₹13.23 in the same period last year. For the full year, the basic EPS was ₹53.98. The extract of the audited standalone and consolidated financial results was filed with stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Summary

Sree Rayalaseema Hi-Strength Hypo Limited has notified the stock exchanges of an upcoming board meeting scheduled for Saturday, May 30, 2026, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed on May 14, 2026, and signed by Company Secretary V. Surekha.

Board Meeting Agenda

The meeting of the Board of Directors has been convened to address key financial and shareholder-related matters for the concluded fiscal year. The following items are on the agenda:

• Approval of Standalone and Consolidated Audited Financial Results for the fourth quarter and financial year ended March 31, 2026
• Recommendation of final dividend, if any, for the financial year ending March 31, 2026

The key details of the scheduled board meeting are summarised below:

Trading Window Closure

In accordance with the company's earlier intimation, the Trading Window for dealing in shares of Sree Rayalaseema Hi-Strength Hypo has been closed from April 1, 2026. The trading window will remain closed until 48 hours after the declaration of audited financial results on May 30, 2026. This restriction applies to designated persons and insiders as per applicable insider trading regulations.

The intimation was submitted to both BSE Limited and the National Stock Exchange of India Ltd, and was duly signed by V. Surekha, Company Secretary, on behalf of Sree Rayalaseema Hi-Strength Hypo Limited.